Supplementary Table 1 from A Mendelian Randomization Analysis of 55 Genetically Predicted Metabolic Traits with Breast Cancer Survival Outcomes in the Pathways Study
posted on 2023-06-22, 14:20authored byPeter N. Fiorica, Haiyang Sheng, Qianqian Zhu, Janise M. Roh, Cecile A. Laurent, Isaac J. Ergas, Jennifer Delmerico, Marilyn L. Kwan, Lawrence H. Kushi, Christine B. Ambrosone, Song Yao
Polygenic score models pulled from the polygenic score catalog
Funding
HHS | NIH | National Cancer Institute (NCI)
HHS | National Institutes of Health (NIH)
Breast Cancer Research Foundation (BCRF)
History
ARTICLE ABSTRACT
To our knowledge, this is the largest study of PGS for metabolic traits with breast cancer prognosis. The findings revealed significant associations of PGS for cardiovascular disease, hypertension, and cystatin C levels with several breast cancer survival outcomes. These findings implicate an underappreciated role of metabolic traits in breast cancer prognosis that would warrant further exploration.